Risedronic acid + HRT increases postmenopausal BMD

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1295, 2001-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HRT + alendronic acid: superior BMD increases in elderly women

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Alendronic acid increases BMD in Crohn's disease

Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Once-monthly risedronic acid is noninferior to daily risedronic acid in the treatment of postmenopausal osteoporosis

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Risedronic acid prevents bone loss in postmenopausal women with breast cancer, with or without aromatase inhibitor (AI) therapy,

Inpharma, Vol. 1, Iss. 1637, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

QOL effect of HRT in postmenopausal women

Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite